FDA approves first preservative-free formulation of latanoprost
- Posted on: Sep 19 2018
- Leave a response
Regulatory officials have approved Xelpros 0.005%, a first-line treatment for open-angle glaucoma and ocular hypertension that lacks the preservative benzalkonium chloride.
Source: AAO
Posted in: Uncategorized
